DANA STALLINGS: Open Payments
NPI 1770021545 · FRANKLIN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$72,721 in 163 payments from 18 companies in 2025. Trend: 2023 $55,890 · 2024 $52,868 · 2025 $72,721
Speaker / faculty: $56,260Travel & lodging: $10,897Food & beverage: $3,560Consulting: $2,000Education: $4
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 82 | $46,694 |
| Lilly USA, LLC | 49 | $23,560 |
| Novo Nordisk Inc | 4 | $1,472 |
| Corcept Therapeutics | 9 | $411 |
| Globus Medical, Inc. | 1 | $120 |
| Insulet Corporation | 2 | $97 |
| Neurocrine BioSciences, Inc. | 2 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
Products named: MINIMED 780G, MOUNJARO, Korlym, INPEN SMART INSULIN DELIVERY SYSTEM, Senza, Omnipod, INGREZZA, Wegovy.
Industry payments across VA — which companies pay providers there.
